Melanoma Clinical Trials in Fuzhou, Fujian
4 recruitingFuzhou, Fujian, China
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Shanghai Henlius Biotech174 enrolled69 locationsNCT07160335
Recruiting
Phase 3
OH2 Injection in Melanoma
Melanoma
Binhui Biopharmaceutical Co., Ltd.340 enrolled30 locationsNCT05868707
Recruiting
Phase 2
A Study of IBI363 in Subjects With Advanced Melanoma
Melanoma
Innovent Biologics (Suzhou) Co. Ltd.150 enrolled12 locationsNCT06081920
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy
Melanoma
Innovent Biologics (Suzhou) Co. Ltd.180 enrolled31 locationsNCT06797297